The PAPAA Blog
This is a discussion area for anyone with an interest in psoriasis and psoriatic arthritis.
Only registered website members can create a reply. All replies are subject to moderation.
Please be aware that some of these blogs are personal opinions and views, and may not be the views of PAPAA.
We also have an HCP only blog.
As the COVID-19 pandemic has continued, researchers have been able to study individual groups of patients with pre-existing medical conditions – including psoriasis. One especially important question, is whether patients diagnosed with psoriasis, could be more at risk of infection with COVID-19?
In a recent (virtual) meeting of the American…
Encouraging new evidence suggests that biological treatment for psoriasis, may reduce the risk of coronary heart disease.
Biologics have been used in the treatment of psoriasis since the early 2000s. They block the actions of various inflammatory molecules – cytokines – which play a major role in the development of psoriasis and psoriatic…
Clinically extremely vulnerable groups
With the changing COVID-19 restrictions, you may like to know what the definition of clinically extremely vulnerable groups are
People who are defined as clinically extremely vulnerable are at very high risk of severe illness from coronavirus. There are 2 ways you may be identified as clinically extremely…
As the daily news appears to report the rise of positive cases and testing, you may like to read the official statistics from the Government website
The website includes the numbers of cases, deaths and tests. The site also includes graphs and cumulative data. There is also a breakdown for all four UK nations (England, Scotland, Wales and…